Qingyan Sun

机构：Chinese PLA General Hospital, Chinese People's Liberation Army, Shanghai Institute of Pharmaceutical Industry · ORCID：0009-0006-0519-6286

发表论文 105 篇 · 总被引 1478 次 · h-index 23

代表论文

Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456 (2023 · Signal Transduction and Targeted Therapy · 被引 85)
Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer (2022 · JCI Insight · 被引 53)
Ferritinophagy induced ferroptosis in the management of cancer (2023 · Cellular Oncology · 被引 27)
One-dimensional Europium-coordination polymer as luminescent sensor for highly selective and sensitive detection of 2,4,6-trinitrophenol (2021 · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · 被引 26)
Dual ferroptosis induction in N2-TANs and TNBC cells via FTH1 targeting: A therapeutic strategy for triple-negative breast cancer (2025 · Cell Reports Medicine · 被引 23)
Structure-based design of glycyrrhetinic acid derivatives as potent anti-sepsis agents targeting high-mobility group box-1 (2020 · Bioorganic Chemistry · 被引 19)